A consultant accused of over-prescribing chemotherapy to brain cancer patients had an "arrogance" and "went unchallenged", a ...

Medicine has never been a polite topic for longtime Berkshire Hathaway Vice Chair Charlie Munger. The late investing legend ...

Prolia works similarly to alendronate by slowing down the cells that break down bone, called osteoclasts. Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so ...

Investigators evaluated the long-term impact of taxane chemotherapy on patient-reported neuropathy, balance problems, and falls among older breast cancer survivors.

As Jessica Huffman underwent a double mastectomy and chemotherapy for invasive breast cancer two years ago, she felt mostly normal for most of the treatment. The exception was the loss of her long ...

Ron Duguay has a new pep in his step. The Rangers legend, who recently revealed that he’s been battling Stage 4 colon cancer, just received much-needed good news. After a visit with his doctor at City ...

A RECORD number of Brits are ditching the NHS and draining their savings to fund private cancer treatment, figures show.

Cancer patients are giving up on the NHS and going private for chemotherapy in record numbers. Experts said desperate ...

Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant ...

Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...

MRI-guided personalisation of neoadjuvant chemotherapy duration is associated with improved 3-year survival outcomes in patients with stage II-III HER2-positive breast cancer, a new trial reports.